BIOMAT Database Logo BIOMAT Database Logo

Knockdown of OCT4 suppresses the growth and invasion of pancreatic cancer cells through inhibition of the AKT pathway. 2014

Hai Lin, and Li-Hua Sun, and Wei Han, and Tie-Ying He, and Xin-Jian Xu, and Kun Cheng, and Cheng Geng, and Li-Dan Su, and Hao Wen, and Xi-Yan Wang, and Qi-Long Chen
Department of Pancreatic Surgery, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830054, P.R. China.

Octamer‑binding transcription factor 4 (OCT4) is one of the factors associated with self‑renewal and differentiation in cancer stem cells, and is crucial for the progression of various types of human malignancy. However, the expression and function of OCT4 in human pancreatic cancer has not been fully elucidated. The purpose of the present study was to investigate the function and molecular mechanisms of OCT4 in pancreatic cancer cells. The clinical significance of OCT4 expression was assessed by an immunohistochemical assay using a tissue microarray procedure in pancreatic cancer tissues and cells with different degrees of differentiation. A loss‑of‑function approach was used to examine the effects of a lentivirus‑mediated OCT4 small hairpin RNA vector on biological behaviors, including cell proliferative activity and invasive potential. The results demonstrated that the expression levels of OCT4 protein in cancer tissues were significantly elevated compared with those in adjacent non‑cancerous tissues (65.0 vs. 42.5%; P=0.005), which was correlated with tumor differentiation (P=0.008). The knockdown of OCT4 inhibited the proliferation and invasion of pancreatic cancer cells (Panc‑1) expressing high levels of OCT4, accompanied with decreased expression of AKT, proliferating cell nuclear antigen (PCNA) and matrix metalloproteinase‑2 (MMP‑2). In conclusion, the present study reveals that the increased expression of OCT4 is correlated with the differentiation of pancreatic cancer, while knockdown of OCT4 suppresses the growth and invasion of pancreatic cancer cells through inhibition of AKT pathway‑mediated PCNA and MMP‑2 expression, suggesting that OCT4 might serve as a potential therapeutic target for the treatment of pancreatic cancer.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D010190 Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA). Cancer of Pancreas,Pancreatic Cancer,Cancer of the Pancreas,Neoplasms, Pancreatic,Pancreas Cancer,Pancreas Neoplasms,Pancreatic Acinar Carcinoma,Pancreatic Carcinoma,Acinar Carcinoma, Pancreatic,Acinar Carcinomas, Pancreatic,Cancer, Pancreas,Cancer, Pancreatic,Cancers, Pancreas,Cancers, Pancreatic,Carcinoma, Pancreatic,Carcinoma, Pancreatic Acinar,Carcinomas, Pancreatic,Carcinomas, Pancreatic Acinar,Neoplasm, Pancreas,Neoplasm, Pancreatic,Neoplasms, Pancreas,Pancreas Cancers,Pancreas Neoplasm,Pancreatic Acinar Carcinomas,Pancreatic Cancers,Pancreatic Carcinomas,Pancreatic Neoplasm
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015316 Genetic Therapy Techniques and strategies which include the use of coding sequences and other conventional or radical means to transform or modify cells for the purpose of treating or reversing disease conditions. Gene Therapy,Somatic Gene Therapy,DNA Therapy,Gene Therapy, Somatic,Genetic Therapy, Gametic,Genetic Therapy, Somatic,Therapy, DNA,Therapy, Gene,Therapy, Somatic Gene,Gametic Genetic Therapies,Gametic Genetic Therapy,Genetic Therapies,Genetic Therapies, Gametic,Genetic Therapies, Somatic,Somatic Genetic Therapies,Somatic Genetic Therapy,Therapies, Gametic Genetic,Therapies, Genetic,Therapies, Somatic Genetic,Therapy, Gametic Genetic,Therapy, Genetic,Therapy, Somatic Genetic
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic

Related Publications

Hai Lin, and Li-Hua Sun, and Wei Han, and Tie-Ying He, and Xin-Jian Xu, and Kun Cheng, and Cheng Geng, and Li-Dan Su, and Hao Wen, and Xi-Yan Wang, and Qi-Long Chen
Klotho suppresses growth and invasion of colon cancer cells through inhibition of IGF1R-mediated PI3K/AKT pathway.
August 2014, International journal of oncology,
Hai Lin, and Li-Hua Sun, and Wei Han, and Tie-Ying He, and Xin-Jian Xu, and Kun Cheng, and Cheng Geng, and Li-Dan Su, and Hao Wen, and Xi-Yan Wang, and Qi-Long Chen
Knockdown of galectin-1 suppresses the growth and invasion of osteosarcoma cells through inhibition of the MAPK/ERK pathway.
October 2014, Oncology reports,
Hai Lin, and Li-Hua Sun, and Wei Han, and Tie-Ying He, and Xin-Jian Xu, and Kun Cheng, and Cheng Geng, and Li-Dan Su, and Hao Wen, and Xi-Yan Wang, and Qi-Long Chen
Knockdown of DDX46 suppresses the proliferation and invasion of gastric cancer through inactivating Akt/GSK-3β/β-catenin pathway.
February 2021, Experimental cell research,
Hai Lin, and Li-Hua Sun, and Wei Han, and Tie-Ying He, and Xin-Jian Xu, and Kun Cheng, and Cheng Geng, and Li-Dan Su, and Hao Wen, and Xi-Yan Wang, and Qi-Long Chen
Knockdown of TRIM31 suppresses proliferation and invasion of gallbladder cancer cells by down-regulating MMP2/9 through the PI3K/Akt signaling pathway.
July 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Hai Lin, and Li-Hua Sun, and Wei Han, and Tie-Ying He, and Xin-Jian Xu, and Kun Cheng, and Cheng Geng, and Li-Dan Su, and Hao Wen, and Xi-Yan Wang, and Qi-Long Chen
Kin17 knockdown suppresses the migration and invasion of cervical cancer cells through NF-κB-Snail pathway.
January 2020, International journal of clinical and experimental pathology,
Hai Lin, and Li-Hua Sun, and Wei Han, and Tie-Ying He, and Xin-Jian Xu, and Kun Cheng, and Cheng Geng, and Li-Dan Su, and Hao Wen, and Xi-Yan Wang, and Qi-Long Chen
Knockdown of TRIM37 suppresses the proliferation, migration and invasion of glioma cells through the inactivation of PI3K/Akt signaling pathway.
March 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Hai Lin, and Li-Hua Sun, and Wei Han, and Tie-Ying He, and Xin-Jian Xu, and Kun Cheng, and Cheng Geng, and Li-Dan Su, and Hao Wen, and Xi-Yan Wang, and Qi-Long Chen
CBX7 suppresses cell proliferation, migration, and invasion through the inhibition of PTEN/Akt signaling in pancreatic cancer.
January 2017, Oncotarget,
Hai Lin, and Li-Hua Sun, and Wei Han, and Tie-Ying He, and Xin-Jian Xu, and Kun Cheng, and Cheng Geng, and Li-Dan Su, and Hao Wen, and Xi-Yan Wang, and Qi-Long Chen
Id4 Suppresses the Growth and Invasion of Colorectal Cancer HCT116 Cells through CK18-Related Inhibition of AKT and EMT Signaling.
January 2021, Journal of oncology,
Hai Lin, and Li-Hua Sun, and Wei Han, and Tie-Ying He, and Xin-Jian Xu, and Kun Cheng, and Cheng Geng, and Li-Dan Su, and Hao Wen, and Xi-Yan Wang, and Qi-Long Chen
Knockdown of E2F4 suppresses the growth of ovarian cancer cells through the cell cycle pathway.
January 2021, International journal of clinical and experimental pathology,
Hai Lin, and Li-Hua Sun, and Wei Han, and Tie-Ying He, and Xin-Jian Xu, and Kun Cheng, and Cheng Geng, and Li-Dan Su, and Hao Wen, and Xi-Yan Wang, and Qi-Long Chen
Knockdown of KIF15 suppresses proliferation of prostate cancer cells and induces apoptosis through PI3K/Akt signaling pathway.
September 2023, Cell death discovery,
Copied contents to your clipboard!